Objective: The purpose of this study was to evaluate the efficacy, side-effect profile, and
follow-up rates in women who obtain a medical abortion in a nonresearch setting. Study …

DESIGN: A retrospective analysis of 386 women who underwent termination of pregnancy
between 12 and 24 weeks' gestation. METHODS: Each woman received 200 mg …

Aim To compare the efficacy of different intervals of misoprostol administration
(simultaneously vis-à-vis 24 h), after mifepristone, in women undergoing medical termination …

Objective To determine the efficacy of oral mifepristone followed by vaginal misoprostol 6
hours later compared with the standard 36‐to 48‐hour regimen for medical termination of …

In September 2000, the Food and Drug Administration (FDA) approved mifepristone (also
known by the trade name Mifeprex or its original French name, RU-486) for use along with a …

INTRODUCTION: A growing body of literature has shown that misoprostol alone could be
effective for early medical abortion. We evaluated seven potential regimens in women up to …

Mifepristone-misoprostol medical abortion promises to revolutionize reproductive health-
care. Several simplifications of the standard three clinic visit regimen may be possible …

Background Mifepristone-misoprostol abortion, consisting of oral pills, is potentially simple
and safe enough for use in less-developed countries. But the labour-intensive, costly, clinic …

BACKGROUND: Several studies have now reported the successful use of the sublingual
administration of misoprostol for medical abortion in the first trimester. The objective of this …

OBJECTIVE: To compare outcomes with simultaneous administration of mifepristone and
misoprostol with a regimen in which the drugs are administered at a 24-hour interval for …